Rhenman & Partners Asset Management AB as of March 31, 2021
Portfolio Holdings for Rhenman & Partners Asset Management AB
Rhenman & Partners Asset Management AB holds 92 positions in its portfolio as reported in the March 2021 quarterly 13F filing
| Company (Ticker) | Portfolio Weight | Valued At | Change in Shares | Share Count | Share Price |
|---|---|---|---|---|---|
| Horizon Therapeutics Pub SHS | 3.8 | $55M | 595k | 92.04 | |
| Johnson & Johnson (JNJ) | 3.7 | $53M | 325k | 164.35 | |
| UnitedHealth (UNH) | 2.9 | $42M | 113k | 372.07 | |
| Jazz Pharmaceuticals Shs Usd (JAZZ) | 2.9 | $41M | 250k | 164.37 | |
| Abbvie (ABBV) | 2.8 | $40M | 368k | 108.22 | |
| Medtronic SHS (MDT) | 2.8 | $40M | 335k | 118.13 | |
| Vertex Pharmaceuticals Incorporated (VRTX) | 2.5 | $36M | 168k | 214.89 | |
| Teladoc (TDOC) | 2.4 | $35M | 190k | 181.75 | |
| Guardant Health (GH) | 2.4 | $34M | 225k | 152.65 | |
| Anthem (ELV) | 2.4 | $34M | 95k | 358.95 | |
| CVS Caremark Corporation (CVS) | 2.4 | $34M | 450k | 75.23 | |
| Abbott Laboratories (ABT) | 2.3 | $33M | 275k | 119.84 | |
| Eli Lilly & Co. (LLY) | 2.2 | $32M | 170k | 186.82 | |
| Humana (HUM) | 2.0 | $29M | 69k | 419.25 | |
| Centene Corporation (CNC) | 1.9 | $27M | 420k | 63.91 | |
| Cigna Corp (CI) | 1.9 | $27M | 110k | 241.74 | |
| Nektar Therapeutics (NKTR) | 1.8 | $26M | 1.3M | 20.00 | |
| Boston Scientific Corporation (BSX) | 1.8 | $26M | 670k | 38.65 | |
| Mirati Therapeutics | 1.8 | $26M | 150k | 171.30 | |
| Abiomed | 1.7 | $25M | 78k | 318.73 | |
| Axonics Modulation Technolog (AXNX) | 1.7 | $25M | 410k | 59.89 | |
| Novocure Ord Shs (NVCR) | 1.7 | $24M | 180k | 132.18 | |
| EXACT Sciences Corporation (EXAS) | 1.6 | $23M | 175k | 131.78 | |
| Gilead Sciences (GILD) | 1.6 | $23M | 350k | 64.63 | |
| Acceleron Pharma | 1.5 | $22M | 160k | 135.61 | |
| Intuitive Surgical Com New (ISRG) | 1.5 | $21M | 29k | 738.93 | |
| Merck & Co (MRK) | 1.5 | $21M | 270k | 77.09 | |
| Zimmer Holdings (ZBH) | 1.5 | $21M | 130k | 160.08 | |
| Becton, Dickinson and (BDX) | 1.4 | $21M | 85k | 243.15 | |
| Thermo Fisher Scientific (TMO) | 1.4 | $21M | 45k | 456.38 | |
| Bristol Myers Squibb (BMY) | 1.4 | $21M | 325k | 63.13 | |
| AmerisourceBergen (COR) | 1.4 | $20M | 168k | 118.07 | |
| Cooper Cos Com New | 1.3 | $19M | 50k | 384.10 | |
| Alnylam Pharmaceuticals (ALNY) | 1.3 | $19M | 135k | 141.19 | |
| Macrogenics (MGNX) | 1.2 | $17M | 545k | 31.85 | |
| McKesson Corporation (MCK) | 1.2 | $17M | 88k | 195.05 | |
| Esperion Therapeutics (ESPR) | 1.2 | $17M | 592k | 28.05 | |
| Baxter International (BAX) | 1.1 | $16M | 190k | 84.34 | |
| Intra Cellular Therapies (ITCI) | 1.1 | $16M | 458k | 33.93 | |
| Neurocrine Biosciences (NBIX) | 1.1 | $15M | 155k | 97.25 | |
| Hca Holdings (HCA) | 1.0 | $14M | 75k | 188.35 | |
| Biohaven Pharmaceutical Holding | 1.0 | $14M | 200k | 68.35 | |
| BioMarin Pharmaceutical (BMRN) | 0.9 | $14M | 180k | 75.51 | |
| Aerie Pharmaceuticals | 0.9 | $13M | 750k | 17.87 | |
| Apellis Pharmaceuticals (APLS) | 0.8 | $12M | 270k | 42.91 | |
| Livanova SHS (LIVN) | 0.8 | $11M | 155k | 73.73 | |
| Seagen | 0.8 | $11M | 80k | 138.86 | |
| Xencor (XNCR) | 0.7 | $10M | 235k | 43.06 | |
| Sangamo Biosciences (SGMO) | 0.7 | $9.6M | 765k | 12.53 | |
| Regeneron Pharmaceuticals (REGN) | 0.7 | $9.5M | 20k | 473.15 | |
| Iovance Biotherapeutics (IOVA) | 0.7 | $9.3M | 295k | 31.66 | |
| Edwards Lifesciences (EW) | 0.6 | $9.2M | 110k | 83.64 | |
| Accolade (ACCD) | 0.6 | $9.1M | 200k | 45.37 | |
| Radius Health Com New | 0.6 | $9.0M | 430k | 20.86 | |
| G1 Therapeutics (GTHX) | 0.5 | $7.8M | 325k | 24.06 | |
| 1life Healthcare | 0.5 | $7.8M | 200k | 39.08 | |
| Dynavax Technologies Corp Com New (DVAX) | 0.5 | $7.7M | 786k | 9.83 | |
| Essa Pharma Com New (EPIX) | 0.5 | $7.6M | 260k | 29.05 | |
| Silk Road Medical Inc Common (SILK) | 0.5 | $7.4M | 146k | 50.65 | |
| Fibrogen (FGEN) | 0.5 | $6.9M | 200k | 34.71 | |
| Phathom Pharmaceuticals (PHAT) | 0.5 | $6.6M | 175k | 37.56 | |
| Shockwave Med (SWAV) | 0.5 | $6.5M | 50k | 130.26 | |
| Meiragtx Holdings (MGTX) | 0.5 | $6.5M | 450k | 14.43 | |
| Adverum Biotechnologies | 0.4 | $6.4M | 650k | 9.86 | |
| Oak Street Health | 0.4 | $6.2M | 115k | 54.27 | |
| Inovalon Hldgs Com Cl A | 0.4 | $6.2M | 215k | 28.78 | |
| Revance Therapeutics (RVNC) | 0.4 | $6.1M | 220k | 27.95 | |
| Alexion Pharmaceuticals | 0.4 | $6.1M | 40k | 152.90 | |
| Zai Lab Adr (ZLAB) | 0.4 | $6.0M | 45k | 133.42 | |
| Royalty Pharma Shs Class A (RPRX) | 0.4 | $5.7M | 130k | 43.62 | |
| Biogen Idec (BIIB) | 0.4 | $5.5M | 20k | 279.74 | |
| Health Catalyst (HCAT) | 0.4 | $5.4M | 115k | 46.77 | |
| Rigel Pharmaceuticals Com New (RIGL) | 0.4 | $5.2M | 1.5M | 3.42 | |
| Annexon (ANNX) | 0.3 | $5.0M | 180k | 27.84 | |
| R1 Rcm | 0.3 | $4.9M | 200k | 24.68 | |
| Myovant Sciences | 0.3 | $4.6M | 225k | 20.58 | |
| Stereotaxis Com New (STXS) | 0.3 | $4.6M | 684k | 6.72 | |
| ImmunoGen | 0.3 | $4.5M | 550k | 8.10 | |
| Arena Pharmaceuticals Com New | 0.3 | $4.2M | 60k | 69.38 | |
| Nuance Communications | 0.3 | $3.9M | 90k | 43.64 | |
| Alkermes SHS (ALKS) | 0.3 | $3.9M | 209k | 18.68 | |
| American Well Corp Cl A (AMWL) | 0.2 | $3.4M | 194k | 17.37 | |
| Ionis Pharmaceuticals (IONS) | 0.2 | $3.4M | 75k | 44.96 | |
| Viewray (VRAYQ) | 0.2 | $3.4M | 775k | 4.35 | |
| Phreesia (PHR) | 0.2 | $3.1M | 60k | 52.10 | |
| Glaukos (GKOS) | 0.2 | $2.9M | 35k | 83.94 | |
| Goodrx Hldgs Com Cl A (GDRX) | 0.2 | $2.9M | 75k | 39.03 | |
| Veeva Sys Cl A Com (VEEV) | 0.2 | $2.9M | 11k | 261.27 | |
| Nextgen Healthcare | 0.2 | $2.7M | 150k | 18.10 | |
| Deciphera Pharmaceuticals (DCPH) | 0.2 | $2.7M | 60k | 44.83 | |
| Epizyme | 0.2 | $2.3M | 265k | 8.71 | |
| Pieris Pharmaceuticals (PIRS) | 0.1 | $771k | 300k | 2.57 |
